Iveta Bernatova - Search Results

Year	Number of Results
2002	2
2003	2
2004	4
2005	1
2006	2
2008	1
2009	2
2010	3
2011	3
2012	3
2013	4
2014	4
2015	3
2016	2
2017	3
2018	2
2019	1
2020	4
2021	6
2022	2

1

The Molecular Mechanisms of Iron Metabolism and Its Role in Cardiac Dysfunction and Cardioprotection.

Ravingerová T, Kindernay L, Barteková M, Ferko M, Adameová A, Zohdi V, Bernátová I, Ferenczyová K, Lazou A. Ravingerová T, et al. Among authors: bernatova i. Int J Mol Sci. 2020 Oct 24;21(21):7889. doi: 10.3390/ijms21217889. Int J Mol Sci. 2020. PMID: 33114290 Free PMC article. Review.

2

L-NAME in the cardiovascular system - nitric oxide synthase activator?

Kopincová J, Púzserová A, Bernátová I. Kopincová J, et al. Among authors: bernatova i. Pharmacol Rep. 2012;64(3):511-20. doi: 10.1016/s1734-1140(12)70846-0. Pharmacol Rep. 2012. PMID: 22814004 Free article. Review.

3

Endothelium in diseased states.

Bernatova I, Andriantsitohaina R, Arribas SM, Matchkov VV. Bernatova I, et al. Biomed Res Int. 2014;2014:810436. doi: 10.1155/2014/810436. Epub 2014 Apr 30. Biomed Res Int. 2014. PMID: 24877134 Free PMC article. No abstract available.

4

Vascular Effects of Low-Dose ACE2 Inhibitor MLN-4760-Benefit or Detriment in Essential Hypertension?

Berenyiova A, Bernatova I, Zemancikova A, Drobna M, Cebova M, Golas S, Balis P, Liskova S, Valaskova Z, Krskova K, Zorad S, Dayar E, Cacanyiova S. Berenyiova A, et al. Among authors: bernatova i. Biomedicines. 2021 Dec 24;10(1):38. doi: 10.3390/biomedicines10010038. Biomedicines. 2021. PMID: 35052717 Free PMC article.

5

Biological activities of (-)-epicatechin and (-)-epicatechin-containing foods: Focus on cardiovascular and neuropsychological health.

Bernatova I. Bernatova I. Biotechnol Adv. 2018 May-Jun;36(3):666-681. doi: 10.1016/j.biotechadv.2018.01.009. Epub 2018 Feb 2. Biotechnol Adv. 2018. PMID: 29355598 Review.

6

Mechanisms Modified by (-)-Epicatechin and Taxifolin Relevant for the Treatment of Hypertension and Viral Infection: Knowledge from Preclinical Studies.

Bernatova I, Liskova S. Bernatova I, et al. Antioxidants (Basel). 2021 Mar 16;10(3):467. doi: 10.3390/antiox10030467. Antioxidants (Basel). 2021. PMID: 33809620 Free PMC article. Review.

7

Endothelial dysfunction in experimental models of arterial hypertension: cause or consequence?

Bernatova I. Bernatova I. Biomed Res Int. 2014;2014:598271. doi: 10.1155/2014/598271. Epub 2014 Mar 13. Biomed Res Int. 2014. PMID: 24738065 Free PMC article. Review.

8

Ultra-Small Superparamagnetic Iron-Oxide Nanoparticles Exert Different Effects on Erythrocytes in Normotensive and Hypertensive Rats.

Radosinska J, Jasenovec T, Radosinska D, Balis P, Puzserova A, Skratek M, Manka J, Bernatova I. Radosinska J, et al. Among authors: bernatova i. Biomedicines. 2021 Apr 2;9(4):377. doi: 10.3390/biomedicines9040377. Biomedicines. 2021. PMID: 33918438 Free PMC article.

9

Endothelial dysfunction in spontaneously hypertensive rats: focus on methodological aspects.

Bernatova I, Conde MV, Kopincova J, González MC, Puzserova A, Arribas SM. Bernatova I, et al. J Hypertens Suppl. 2009 Aug;27(6):S27-31. doi: 10.1097/01.hjh.0000358834.18311.fc. J Hypertens Suppl. 2009. PMID: 19633448 Review.

10

Pleiotropic preconditioning-like cardioprotective effects of hypolipidemic drugs in acute ischemia-reperfusion in normal and hypertensive rats.

Ravingerová T, Ledvényiová-Farkašová V, Ferko M, Barteková M, Bernátová I, Pecháňová O, Adameová A, Kolář F, Lazou A. Ravingerová T, et al. Among authors: bernatova i. Can J Physiol Pharmacol. 2015 Jul;93(7):495-503. doi: 10.1139/cjpp-2014-0502. Epub 2015 Feb 26. Can J Physiol Pharmacol. 2015. PMID: 25965412 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results